Lack of Association Between the ACE2 G8790A Gene Variation and Risk for Basal Cell Carcinoma
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..
BACKGROUND/AIM: The G8790A (rs2285666) functional polymorphism of the angiotensin-converting enzyme 2 (ACE2) gene influences alternative mRNA splicing and quantitatively affects the enzyme's production. Specifically, the presence of the A allele has been associated with higher ACE2 plasma levels. In this study, we investigated the possible association of the functional polymorphism ACE2-G8790A with the pathogenesis of basal cell carcinoma (BCC).
PATIENTS AND METHODS: A total of 190 DNA samples were studied, including 91 BCC patients and 99 controls of Greek origin. Molecular genotyping for the ACE2 G8790A polymorphism was carried out by PCR amplification, followed by AluI enzyme digestion and agarose gel electrophoresis of the DNA fragments.
RESULTS: The allelic and genotypic frequencies presented no statistical difference between the patient and the control group.
CONCLUSION: There is no association between the ACE2 G8790A polymorphism and pathogenesis of BCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Anticancer research - 41(2021), 8 vom: 19. Aug., Seite 4021-4026 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gintoni, Iphigenia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ACE2 protein, human |
|---|
| Anmerkungen: |
Date Completed 28.07.2021 Date Revised 28.07.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.21873/anticanres.15201 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328271675 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328271675 | ||
| 003 | DE-627 | ||
| 005 | 20231225202612.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21873/anticanres.15201 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1094.xml |
| 035 | |a (DE-627)NLM328271675 | ||
| 035 | |a (NLM)34281868 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gintoni, Iphigenia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lack of Association Between the ACE2 G8790A Gene Variation and Risk for Basal Cell Carcinoma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.07.2021 | ||
| 500 | |a Date Revised 28.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | ||
| 520 | |a BACKGROUND/AIM: The G8790A (rs2285666) functional polymorphism of the angiotensin-converting enzyme 2 (ACE2) gene influences alternative mRNA splicing and quantitatively affects the enzyme's production. Specifically, the presence of the A allele has been associated with higher ACE2 plasma levels. In this study, we investigated the possible association of the functional polymorphism ACE2-G8790A with the pathogenesis of basal cell carcinoma (BCC) | ||
| 520 | |a PATIENTS AND METHODS: A total of 190 DNA samples were studied, including 91 BCC patients and 99 controls of Greek origin. Molecular genotyping for the ACE2 G8790A polymorphism was carried out by PCR amplification, followed by AluI enzyme digestion and agarose gel electrophoresis of the DNA fragments | ||
| 520 | |a RESULTS: The allelic and genotypic frequencies presented no statistical difference between the patient and the control group | ||
| 520 | |a CONCLUSION: There is no association between the ACE2 G8790A polymorphism and pathogenesis of BCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Basal cell carcinoma | |
| 650 | 4 | |a DNA polymorphism | |
| 650 | 4 | |a G8790A | |
| 650 | 4 | |a angiotensin | |
| 650 | 4 | |a angiotensin-converting enzyme 2 | |
| 650 | 4 | |a rs2285666 | |
| 650 | 4 | |a skin cancer | |
| 650 | 7 | |a ACE2 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 700 | 1 | |a Vassiliou, Stavros |e verfasserin |4 aut | |
| 700 | 1 | |a Avgoustidis, Dimitris |e verfasserin |4 aut | |
| 700 | 1 | |a Adamopoulou, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Zavras, Nikolaos |e verfasserin |4 aut | |
| 700 | 1 | |a Papakosta, Veronica |e verfasserin |4 aut | |
| 700 | 1 | |a Vlachakis, Dimitris |e verfasserin |4 aut | |
| 700 | 1 | |a Yapijakis, Christos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d 1987 |g 41(2021), 8 vom: 19. Aug., Seite 4021-4026 |w (DE-627)NLM012601454 |x 1791-7530 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2021 |g number:8 |g day:19 |g month:08 |g pages:4021-4026 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21873/anticanres.15201 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2021 |e 8 |b 19 |c 08 |h 4021-4026 | ||